Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of Bupivacaine for Cesarean Delivery in Super Obese Parturients
NCT03781388Phase 4Completed
- Sponsor
- Duke University
- Start
- May 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in cesarean delivery (2 arms), sponsored by Duke University. Primary endpoints: Number of Participants With Successful Blocks for Induction at 10 minutes, Number of Participants With Successful Blocks for Operation at 90 minutes and 1 more. Started May 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
cesarean delivery
Beyond the preview
Go deeper on NCT03781388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781388.